Literature DB >> 16432277

High density lipoproteins bind Abeta and apolipoprotein C-II amyloid fibrils.

Leanne M Wilson1, Chi L L Pham, Alicia J Jenkins, John D Wade, Andrew F Hill, Matthew A Perugini, Geoffrey J Howlett.   

Abstract

Disease-associated amyloid deposits contain both fibrillar and nonfibrillar components. The majority of these amyloid components originate or coexist in the bloodstream. To understand the nature of the interaction between the nonfibrillar and fibrillar components, we have developed a centrifugation method to isolate fibril binding proteins from human serum. Amyloid fibrils composed of either Abeta peptide or apolipoprotein C-II (apoC-II) cosedimented with specific serum proteins. Gel electrophoresis, mass spectrometry peptide fingerprinting, and Western analysis identified the major binding species as proteins found in HDL particles, including apoA-I, apoA-II, apoE, clusterin, and serum amyloid A. Sedimentation analysis showed that purified human HDL and recombinant apoA-I lipid particles bound directly to Abeta and apoC-II amyloid fibrils. These studies reveal a novel function of HDL that may contribute to the well-established protective effect of this lipoprotein class in heart disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432277     DOI: 10.1194/jlr.C500022-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  7 in total

1.  NBD-labeled phospholipid accelerates apolipoprotein C-II amyloid fibril formation but is not incorporated into mature fibrils.

Authors:  Timothy M Ryan; Michael D W Griffin; Michael F Bailey; Peter Schuck; Geoffrey J Howlett
Journal:  Biochemistry       Date:  2011-10-13       Impact factor: 3.162

2.  High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.

Authors:  Laila Abdullah; Cheryl Luis; Daniel Paris; Ghania Ait-ghezala; Benoit Mouzon; Elizabeth Allen; Julia Parrish; Myles A Mullan; Scott Ferguson; Marcie Wood; Fiona Crawford; Michael Mullan
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

3.  High-density lipoproteins suppress Aβ-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture.

Authors:  Jérôme Robert; Emily B Button; Sophie Stukas; Guilaine K Boyce; Ebrima Gibbs; Catherine M Cowan; Megan Gilmour; Wai Hang Cheng; Sonja K Soo; Brian Yuen; Arvin Bahrabadi; Kevin Kang; Iva Kulic; Gordon Francis; Neil Cashman; Cheryl L Wellington
Journal:  Mol Neurodegener       Date:  2017-08-22       Impact factor: 14.195

4.  Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis.

Authors:  Sadichhya Lohani; Emily Schuiteman; Lohit Garg; Dhiraj Yadav; Sami Zarouk
Journal:  Case Rep Nephrol       Date:  2016-10-20

5.  Conservation of the Amyloid Interactome Across Diverse Fibrillar Structures.

Authors:  Dennis Wilkens Juhl; Michael Wulff Risør; Carsten Scavenius; Casper Bøjer Rasmussen; Daniel Otzen; Niels Chr Nielsen; Jan J Enghild
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

Review 6.  Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.

Authors:  M Mahafuzur Rahman; Christofer Lendel
Journal:  Mol Neurodegener       Date:  2021-08-28       Impact factor: 14.195

7.  Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.

Authors:  Jerome Robert; Emily B Button; Emma M Martin; Luke McAlary; Zoe Gidden; Megan Gilmour; Guilaine Boyce; Tara M Caffrey; Andrew Agbay; Amanda Clark; Judith M Silverman; Neil R Cashman; Cheryl L Wellington
Journal:  Mol Neurodegener       Date:  2020-03-25       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.